Role of Bruton's tyrosine kinase in B cells and malignancies.

about

Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency Memory B Cells Activate Brain-Homing, Autoreactive CD4 T Cells in Multiple Sclerosis Simulation of the Dynamics of Primary Immunodeficiencies in B Cells

P2860

Q57110641-421C3E40-984F-4D1E-9C0A-D5AFCE5742CA Q58709181-D3A8CBC3-F9D1-4F06-B323-2A82569E33FF Q58803473-7A9877EC-BC69-4F59-A0ED-01CA9BEA5B7F

P2860

Role of Bruton's tyrosine kinase in B cells and malignancies.

Item

http://www.wikidata.org/entity/Q49888075

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Role of Bruton's tyrosine kinase in B cells and malignancies.

@en

Role of Bruton's tyrosine kinase in B cells and malignancies.

@nl

type

Item

label

Role of Bruton's tyrosine kinase in B cells and malignancies.

@en

Role of Bruton's tyrosine kinase in B cells and malignancies.

@nl

prefLabel

Role of Bruton's tyrosine kinase in B cells and malignancies.

@en

Role of Bruton's tyrosine kinase in B cells and malignancies.

@nl

P1476

Role of Bruton's tyrosine kinase in B cells and malignancies.

@en

P2093

Floris Dammeijer

http://www.w3.org/2001/XMLSchema#string

Rudi W Hendriks

http://www.w3.org/2001/XMLSchema#string

Simar Pal Singh

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Hallmarks of Cancer: The Next Generation

Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein

Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia

Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation

Targeting cancer with kinase inhibitors

P2888

s12943-018-0779-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S12943-018-0779-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101066782

http://www.w3.org/2001/XMLSchema#string

P698

29455639

http://www.w3.org/2001/XMLSchema#string

P921

dysplasia

B-cell lymphoma

hemic and immune systems

Achyolli

Anzim

P932

5817726

http://www.w3.org/2001/XMLSchema#string

Role of Bruton's tyrosine kinase in B cells and malignancies.

about

P2860

P2860

Role of Bruton's tyrosine kinase in B cells and malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P6179

P698

P921

P932